ELOVL2 and breast cancer: Our study constructed the prognostic signature based on breast cancer PD-1/PD-L1 pathway molecular typing-related genes (IFNG, JCHAIN, ELOVL2, PIGR, PAGE5, ACTL8, and CLEC3A).